Shivalik Rasayan logo

Shivalik Rasayan financials and balance sheet

NSE: SHIVALIKBSE: 539148Fertilizers & AgrochemicalsSmall Cap

Last close ₹306.50down ₹12.00 (3.77%)BSE ₹305.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹318.50.

52-week range of traded prices to 23 Oct 2026
₹206.40Low, 25 Jun 2026₹471.00High, 31 Oct 2025
Market cap
₹491 Cr1,927th largest listed
P/E
35.9
P/B
0.8
Dividend yield
0.16%
ROE
2.4%
ROCE
3.9%
Debt to equity
0.19
Volume, NSE
1,21,29550.4% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Shivalik Rasayan annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹368 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue368
  2. Materials and goods−188
  3. Employee costs−61
  4. Other expenses−73
  5. Operating profit46
  6. Depreciation−19
  7. Other income+4.1
  8. One-off items0.0
  9. Finance costs−9.6
  10. Profit before tax21
  11. Tax−3.5
  12. Net profit18

What the company owns

  • Plant, investments and other assets₹522 Cr
  • Inventory₹147 Cr
  • Receivables₹115 Cr
  • Cash and bank₹34 Cr

What pays for it: net worth and liabilities

  • Net worth₹599 Cr
  • Borrowings₹114 Cr
  • Owed to suppliers₹80 Cr
  • Other liabilities₹26 Cr

Shivalik Rasayan business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them. A segment at a loss has no share of profit.Shivalik Rasayan segment results by quarter

Revenue by segment

₹358 CrTotal
  • Pharma Formulation₹198 Cr55.2% of total
  • Agrochemicals₹151 Cr42.2% of total
  • Active Pharma Ingredient (API)₹9 Cr2.5% of total

Profit by segment

  • Pharma Formulation₹15.5 Cr41.3% of total
  • Agrochemicals₹22.0 Cr58.7% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Pharma Formulation

    Revenue, ₹ crore
    Profit, ₹ crore
  • Agrochemicals

    Revenue, ₹ crore
    Profit, ₹ crore
  • Active Pharma Ingredient (API)

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses––198215239273311358
Company revenue, as in its results171186198215234273312368
Revenue––113115143179163198
Revenue growth–––2.4%24.2%25.1%−9.3%21.7%
Profit––171820171315
Profit growth–––3.6%10.4%−12.5%−25.4%18.8%
Margin––15.5%15.7%13.9%9.7%8.0%7.8%
Return on capital––11.6%12.4%10.3%7.4%5.4%5.0%
Assets––194226279295294356
Liabilities––437985585048
Capital employed––150146193237244308
Revenue––85968888142151
Revenue––038569
Revenue––00––010
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Shivalik Rasayan quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 3 JulMar 2021Filed 28 JunMar 2022Filed 20 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 27 May
Revenue from operations123155171186198215234273312368
106131147158160168192234272322
Materials and goods bought729411111410794115140160188
Employee costs–121316213037475561
Other expenses–252328324440475673
Operating profit before depreciation18242329384743394046
Operating margin14.4%15.3%13.6%15.3%19.2%21.8%18.3%14.4%12.9%12.4%
Materials, % of revenue–60.6%65.2%61.0%54.1%43.8%48.9%51.2%51.5%51.2%
Employee costs, % of revenue–7.7%7.7%8.8%10.7%13.9%15.8%17.2%17.6%16.5%
Other expenses, % of revenue–16.4%13.5%14.9%16.0%20.5%17.0%17.3%18.0%19.9%
Depreciation and amortisation223491112121619
Operating profit after depreciation15212025293631272427
Other income1383145484
Finance costs54212248910
One-off items0000000000
Profit before tax11202627293732232321
3555432534
8152122253430182018
Net margin6.9%9.8%12.3%11.8%12.6%16.0%12.7%6.6%6.6%4.9%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Belonging to the company's shareholders is left blank for the years to Mar 2018 and Mar 2019: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because a split, bonus or rights issue between the start of the period and the filing changed the share count the earnings per share is on. Belonging to the company's shareholders is left blank for the years to Mar 2020 and Mar 2021: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the company's periods around it state no share for other owners for the gap to belong to. Belonging to the company's shareholders is left blank for the year to Mar 2022: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the share count moved by more than 5% across the period.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 14 JunMar 2020Filed 3 JulMar 2021Filed 28 JunMar 2022Filed 20 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 27 May
220250259365419508536599
165176179288360508536599
Share capital77777888
Reserves158169172280353500528591
Belonging to outside owners of subsidiaries5473807759–0–
19102940587694114
627591112144158178190
74131215262030
Total assets288328363488578692734819
77171232248317399417437
212158131240262294317382
Net debt−76124−3127386679
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 28 JunMar 2022Filed 20 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 27 May
58.89.9−18.9−6.4−7.6−34.0
65.516.1−13.3−8.02.1−31.1
26.7−32.8−58.5−43.4−46.4−78.9
Receivables−10.7−1.2−14.8−2.0−9.4−19.0
Inventories10.3−28.3−36.8−26.8−15.9−29.4
Payables−8.711.99.9−13.314.013.6
Other working capital35.8−15.2−16.7−1.2−35.2−44.0
Tax paid−6.8−6.2−5.7−4.30.0−2.8
Capital spending65.325.063.279.220.823.3
Free cash flow−6.5−15.1−82.2−85.5−28.4−57.3
−79.1−23.4−70.8−85.8−12.5−21.2
16.079.549.699.210.361.6
Dividends paid0.00.70.72.02.02.1
Shares bought back0.00.00.00.00.00.0
Shares issued0.075.130.087.413.60.8
Net change in cash−4.366.0−40.17.1−9.86.4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Shivalik Rasayan dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 3 JulMar 2021Filed 28 JunMar 2022Filed 20 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 27 May
––₹11.83₹10.16₹12.88₹18.12₹15.02₹10.75₹10.60₹7.71
As stated that year₹24.74₹24.25₹11.83₹10.16₹12.88₹18.12₹15.02₹10.75₹10.60₹7.71
––₹11.83₹10.16₹12.88₹18.12₹15.02₹10.75₹10.60₹7.71
Dividend per share–––––₹0.50₹0.50₹0.50₹0.50₹0.50
Book value per share––₹119.96₹127.93₹129.95₹198.56₹248.73₹326.20₹340.29₹380.37
Dividend payout––––––3.3%4.8%4.7%6.5%
Shareholder yield––––0.0%−5.5%−3.0%−9.5%−1.2%0.4%
Market cap at the year end (₹ crore)862873723059721,346968899979347
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.Shivalik Rasayan PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 3 JulMar 2021Filed 28 JunMar 2022Filed 20 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 27 May
Revenue growth12.3%25.7%9.9%9.2%6.1%8.7%9.2%16.4%14.2%18.0%
Operating profit growth–33.7%−2.1%22.6%32.9%23.2%−8.1%−8.8%2.6%13.8%
Net profit growth174.7%80.2%37.4%5.2%12.5%38.1%−12.9%−39.4%13.0%−12.0%
Earnings per share growth–––−14.1%26.8%40.7%−17.1%−28.4%−1.4%−27.3%
––––––6.7%3.8%3.2%2.1%
–––––––−2.9 pts−0.6 pts−1.1 pts
From the net margin–––––––−2.4 pts−0.4 pts−1.2 pts
From asset turnover–––––––−0.1 pts0.1 pts0.2 pts
From borrowing–––––––−0.5 pts−0.2 pts0.0 pts
Return on capital employed––8.5%9.6%10.2%8.8%6.6%4.6%3.9%3.8%
Cash conversion––––237.0%28.9%−63.5%−35.2%−37.1%−189.0%
Interest cover3.15.89.916.918.714.37.23.52.62.8
Debt to equity––0.090.040.110.110.140.150.180.19
Receivable days––111114127119132116113114
Inventory days––716533148239266268285
Payable days––123171152218209136151155
Cash conversion cycle, days––597949162245230244
Working capital days––14716097148206200221243
Asset turnover––0.590.600.570.500.440.430.440.47
Assets per rupee of net worth––1.741.801.951.821.651.461.371.37
Sales per rupee of plant––4.223.630.940.971.081.280.931.10
Capital spending to depreciation––––7.602.275.456.401.321.24
Plant being built, % of plant in use––63.8%198.3%0.0%1.5%26.4%54.8%––
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
1.6%
Cash from operations against operating profit
−74.2%
Measure10 years5 years3 years
Revenue growth, yearly rate12.8%13.2%16.2%
Profit growth, yearly rate14.7%–−17.7%
Return on equity, average–4.0%3.0%
Return on capital employed, average–5.5%4.1%
Operating margin, average15.8%16.0%13.2%
Net margin, average10.0%9.3%6.0%
Asset turnover, average–0.460.45
Cash conversion cycle, days, average–186240
Interest cover, average8.56.13.0
Debt to equity, average–0.150.17

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−57−48−34
Cash from investing−214−120−21
Cash from financing30017162
Capital spending21212323
Dividends paid862
Shares bought back000
Shares issued for cash2071021
Borrowings raised774620
Borrowings repaid000

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––562225
Altman Z-scorePublished threshold 1.81––5.564.207.258.365.364.704.812.81
Beneish M-scorePublished threshold −1.78––––−3.21−2.40−1.08−2.04−2.45−1.98
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––13.0511.2122.4217.355.689.42
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.56−0.19−0.48−0.85
Receivables growth less revenue growthOur threshold 0 percentage points–––2.5312.27−7.0011.93−14.11−3.401.76
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−8.57−45.31300.8174.7013.890.887.35
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––5.702.182.444.453.402.662.97
Assets under construction, years of additionsOur threshold 2 years of additions–––7.080.000.156.6614.26––
Effective tax ratePublished threshold 17.16 per cent25.1524.7820.0117.4214.257.325.7821.9512.7516.33
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−9.46−12.143.3112.753.13
A threshold marked as ours has no published figure; it is the line we read the check against.